Act-Hib vaccine

a conjugated H. influenza type b-vaccine from Sanofi Pasteur MSD, Solna, Sweden

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

1.	Tetanus 03/26/1999 - "influenzae type B tetanus-conjugated (Act-HIB) vaccine, has been combined in a full liquid formulation with the whole-cell DTP. " 09/01/2004 - "The conjugate ACT-HIB vaccine efficiently overcomes the IgG3 subclass deficiency state and the genetic predisposition for lower responsiveness, providing protection against Hib and tetanus infections. "
2.	Infections 05/01/2010 - "Prevention of Hib-infection using Act-HIB vaccine leads to decrease of acute respiratory disease rates and severity of infections. " 09/01/2004 - "The conjugate ACT-HIB vaccine efficiently overcomes the IgG3 subclass deficiency state and the genetic predisposition for lower responsiveness, providing protection against Hib and tetanus infections. "
3.	Genetic Predisposition to Disease (Genetic Predisposition) 09/01/2004 - "The conjugate ACT-HIB vaccine efficiently overcomes the IgG3 subclass deficiency state and the genetic predisposition for lower responsiveness, providing protection against Hib and tetanus infections. "
4.	Respiratory Tract Diseases (Respiratory Tract Disease) 05/01/2010 - "To assess effectiveness of Act-HIB vaccine forprevention of acute respiratory diseases. "
5.	Haemophilus Infections 05/01/2010 - "Prevention of Hib-infection using Act-HIB vaccine leads to decrease of acute respiratory disease rates and severity of infections. "

1.	Immunoglobulin G (IgG)